Basic Neurochem
"That is very different from a drug actually causing a new cancer." The review emphasizes that for patients with papillary, follicular, or Oncocytic (Hrthle cell) thyroid cancers, current evidence does not support the idea that GLP-1 medications cause these diseases or worsen their course
Weeks 12: Digestion calms, discomfort decreases, energy improves
Figure 2B ), which was treated with stereotactic radiotherapy (SRT
Semaglutide, a GLP-1 agonist initially developed for diabetes management, has gained attention for its ability to promote significant weight loss
As with any new supplement, if you have a pre-existing medical condition or are taking medication, you should consult your doctor first